Abstract
A great variety of viral and nonviral expression systems has been developed and assessed for their ability to transfer genes into somatic cells. In particular, retroviral and adenoviral mediated gene transfer has been extensively studied and improved at least because of their capability to efficiently infect the targeted cells. However, the lack of cell type specificity of viral and nonviral vectors still represents one major obstacle for appropriate and controlled expression of foreign genes. Many attempts have been made to achieve efficient gene delivery by targeting, e.g., retroviral integration via modifications in viral envelope protein sequences, using antibodies as specific mediators in viral infection and pseudotyped viruses, and so on (1, 2, 3, 4).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bushman, F. (1995) Targeting retroviral integration. Science 267, 1443–1444.
Friedmann, T. and Yee, J.-K. (1995) Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med. 1, 275–277.
Kasahara, N., Dozy, A. M., and Kan. Y. W. (1994) Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373–1376.
Salmons, B. and Günzburg, W. H. (1993) Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4, 129–141.
Walther, W. and Stein, U. (1996) Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting. J. Mol. Med. 74, 379–392.
Miller, N. and Whelan, J. (1997) Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8, 803–815.
Boothman, D. A., Lee, I. W., and Sahijdak, W. M. (1994) Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of X-ray-responsive elements for gene therapy. Radiat. Res. 138 (1Suppl.), S68–71.
Hallahan, D. E., Mauceri, H. J., Seung, L. P., Dunphy, E. J., Wayne, J. D., Hanna, N. N., et al. (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1, 786–791.
Williams, G. T. and Morimoto, R. I. (1990) Maximal stress-induced transcription from the human HSP70 promoter requires interactions with the basal promoter elements independent of the rotational alignment. Mol. Cell. Biol. 10, 3125–3136.
Gazit, G., Kane, S. E., Nichols, P., and Lee, A. S. (1995) Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res. 55, 1660–1663.
Dachs, G. U., Patterson, A. V., Firth, J. D., Ratcliffe, P. J., Townsend, K. M. S., Stratford, I. J., and Harris A. L. (1997) Targeting gene expression to hypoxic tumor cells. Nature Med. 3, 515–520.
Blackburn, R. V., Golaforo, S. S., Corry, P. M., and Lee, Y. J. (1998) Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res. 58, 1358–1362.
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., and Gottesmann, M. M. (1990) Heat shock and arsenite in rease expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem 256, 221–226.
Chaudhary, P. M. and Roninson, I. B (1992) Activation of MDR1 (p-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol. Res. 4, 281–290.
Uchiumi, T., Kohno, K., Tanimura, H., Matsuo, K., Sato, S., Uchida Y., and Kuwano, M. (1993) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ. 4, 147–157.
Licht, T., Fiebig, H. H., Bross, K. J., Herrmann, F., Berger, D. P., Shoemaker, R., and Mertelsmann, R. (1991) Induction of multiple drug resistance during anti-neoplastic chemotherapy in vitro. Int. J. Cancer 49, 630–637.
Chaudhary, P. M. and Roninson, I. B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85, 632–639.
Kohno, K., Sato, S.-I., Takano, H., Matsuo, K.-I., and Kuwano, M. (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Comm. 165, 1415–1421.
Stein, U., Walther, W., and Wunderlich, V. (1994) Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Eur. J. Cancer 30A, 1541–1545.
Iwahashi, T., Okochi, E., Ono, K., Sugawara, I., Tsuruo, T., and Mori, S. (1991) Establishment of multidrug resistant human colorectal HCT-15 cell lines and their properties. Anticancer Res. 11, 1309–1312.
Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., and Fidler I. J. (1988) Influence of organ environment on the growth selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48, 6863–6871.
Soule, H. D., Vasquez, J., Long, A., Albert, S., and Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409–1416.
Kohno, K., Sato, S.-I., Uchiumi, T., Takano, H., Kato, S., and Kuwano, M. (1990) Tissue specific enhancer of the human multidrg-resistance (MDR1) gene. J. Biol. Chem. 265, 19,690–19,696.
Brenner, C. A., Daniel, S. L., and Adler, R. R. (1989) Cytokine mapping: observation and quantification of cytokine mRNA in small numbers of cells using the polymerase chain reaction, in Cytokines-A Practical Approach (Balkwill, F. R., ed). Oxford University Press, Oxford, pp. 51–59.
Wu, L., Smythe, A. M., Stinson, S. F., Mullendore, L. A., Monks, A., Scudiero, D. A., et al. (1992) Multidrug resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 52, 3029–3034.
Walther, W., Fichtner, I., and Uckert, W. (1993) Retrovirus-mediated gene transfer of tumor necrosis factor alpha into colon carcinoma cells generates a growth inhibition. Anticancer Res. 13, 1565–1574.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, pp. 1.26–1.28.
Walther, W., Wendt, J., and Stein, U. (1997) Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy. Gene Ther. 4, 544–552.
Stein, U., Walther, W., and Shoemaker, R. H. (1996) Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J. Natl. Cancer Inst. 88, 1383–1392.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Walther, W., Stein, U., Shoemaker, R.H., Schlag, P.M. (2000). Chemotherapy-Inducible Vector for Gene Therapy of Cancer. In: Walther, W., Stein, U. (eds) Gene Therapy of Cancer. Methods in Molecular Medicine™, vol 35. Humana Press. https://doi.org/10.1385/1-59259-086-1:371
Download citation
DOI: https://doi.org/10.1385/1-59259-086-1:371
Publisher Name: Humana Press
Print ISBN: 978-0-89603-714-4
Online ISBN: 978-1-59259-086-5
eBook Packages: Springer Protocols